Necrotising Enterocolitis Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Necrotising Enterocolitis Market is Segmented By Treatment Type (Pharmacological Therapy, Surgical Intervention, Supportive Care), By Diagnosis (Laboratory Tests, Imaging Techniques), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.

Competitive overview of Necrotising Enterocolitis Market

The major players operating in the Global Necrotising Enterocolitis Market include Hollister Incorporated, Medtronic, Nestlé Health Science, Pediatric Therapeutics, Purdue Pharma, Reckitt Benckiser, Sanofi, Shire (now part of Takeda Pharmaceutical Company), Sientra, Smith & Nephew, Thermo Fisher Scientific, Vifor Pharma, Zebra Medical Vision, Astarte Medical and Infant Bacterial Therapeutics.

Necrotising Enterocolitis Market Leaders

  • AbbVie
  • AstraZeneca
  • Baxter International
  • Bristol-Myers Squibb
  • Fresenius Kabi
*Disclaimer: Major players are listed in no particular order.

Necrotising Enterocolitis Market - Competitive Rivalry, 2023

Market Concentration Graph

Necrotising Enterocolitis Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights

Necrotising Enterocolitis Market Report Snapshots

Buy Now